These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23375092)

  • 1. The effect of absolute configuration on activity, subtype selectivity (M3/M2) of 3α-acyloxy-6β-acetoxyltropane derivatives as muscarinic M3 receptor antagonists.
    Wang ZP; Liu HZ; Zhu L; Hu YM; Cui YY; Niu YY; Lu Y; Chen HZ
    Bioorg Med Chem; 2013 Mar; 21(5):1234-9. PubMed ID: 23375092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The absolute configuration plays an important role in muscarinic activity of BGT-A and its analogs.
    Niu YY; Zhu L; Cui YY; Liu HZ; Chen HZ; Lu Y
    Bioorg Med Chem; 2008 Dec; 16(24):10251-6. PubMed ID: 19013075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
    Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
    J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic agonist-mediated heterologous desensitization in isolated ileum requires activation of both muscarinic M2 and M3 receptors.
    Griffin MT; Matsui M; Shehnaz D; Ansari KZ; Taketo MM; Manabe T; Ehlert FJ
    J Pharmacol Exp Ther; 2004 Jan; 308(1):339-49. PubMed ID: 14563784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).
    Peretto I; Forlani R; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Bigogno C; Misiano P; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Delcanale M; Salcedo C; Fernández AG; Imbimbo BP
    J Med Chem; 2007 Apr; 50(7):1571-83. PubMed ID: 17352462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland.
    Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
    Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
    J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
    Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
    J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol.
    Varoli L; Angeli P; Buccioni M; Burnelli S; Cavalli A; Marucci G; Recanatini M
    Farmaco; 2003 Sep; 58(9):651-7. PubMed ID: 13679157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.
    Daly JW; Gupta TH; Padgett WL; Pei XF
    J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel imidazole derivatives with subtype-selective antimuscarinic activity (2).
    Miyachi H; Kiyota H; Segawa M
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2163-8. PubMed ID: 9873506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.
    Lainé DI; Wan Z; Yan H; Zhu C; Xie H; Fu W; Busch-Petersen J; Neipp C; Davis R; Widdowson KL; Blaney FE; Foley J; Bacon AM; Webb EF; Luttmann MA; Burman M; Sarau HM; Salmon M; Palovich MR; Belmonte K
    J Med Chem; 2009 Aug; 52(16):5241-52. PubMed ID: 19630384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.
    Starck JP; Provins L; Christophe B; Gillard M; Jadot S; Lo Brutto P; Quéré L; Talaga P; Guyaux M
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2675-8. PubMed ID: 18359633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
    Pei XF; Gupta TH; Badio B; Padgett WL; Daly JW
    J Med Chem; 1998 Jun; 41(12):2047-55. PubMed ID: 9622546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Potent Muscarinic Receptor Antagonists: Investigation on the Nature of Lipophilic Substituents in the 5- and/or 6-Positions of the 1,4-Dioxane Nucleus.
    Del Bello F; Bonifazi A; Giorgioni G; Piergentili A; Sabbieti MG; Agas D; Dell'Aera M; Matucci R; Górecki M; Pescitelli G; Vistoli G; Quaglia W
    J Med Chem; 2020 Jun; 63(11):5763-5782. PubMed ID: 32374602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative structure-selectivity relationship for M2 selectivity between M1 and M2 of piperidinyl piperidine derivatives as muscarinic antagonists.
    Niu YY; Yang LM; Deng KM; Yao JH; Zhu L; Chen CY; Zhang M; Zhou JE; Shen TX; Chen HZ; Lu Y
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2260-6. PubMed ID: 17289384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
    Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M3/M1-Selective antimuscarinic tropinyl and piperidinyl esters.
    Xu R; Sim MK; Go ML
    Eur J Pharm Sci; 1999 Apr; 8(1):39-47. PubMed ID: 10072477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice.
    Ito Y; Oyunzul L; Yoshida A; Fujino T; Noguchi Y; Yuyama H; Ohtake A; Suzuki M; Sasamata M; Matsui M; Yamada S
    Eur J Pharmacol; 2009 Aug; 615(1-3):201-6. PubMed ID: 19446545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
    Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM
    Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.